Core Laboratories Reports $526.5 Million Revenue for Fiscal Year 2025

Core Laboratories Inc. reported a total revenue of $526.5 million for the fiscal year ended December 31, 2025, reflecting a slight increase of 0.5% compared to $523.8 million in 2024. The company's service revenue, which constitutes the majority of its income, rose by 3% to $399.4 million, driven by increased demand for well completion diagnostic services and laboratory crude assay services, particularly in the U.S. and international markets. However, product sales revenue decreased by 6% to $127.1 million, attributed to a decline in U.S. land-based rig counts and reduced activity in certain international markets.

In terms of profitability, Core Laboratories reported a net income of $30.4 million, down 5.5% from $32.2 million in the previous year. The diluted earnings per share decreased to $0.63 from $0.66 in 2024. The decline in net income was influenced by increased general and administrative expenses, which rose by 14% to $45.4 million, primarily due to higher stock compensation costs and implementation expenses for a new global human capital management system. Operating income also fell by 3.6% to $56.5 million, with operating margins slightly decreasing to 10.7%.

Strategically, Core Laboratories has focused on enhancing its service offerings and expanding its international presence. The company operates in over 50 countries and has approximately 3,300 employees. The recent redomestication transaction, completed on May 1, 2023, aimed to streamline operations and improve corporate governance. The company continues to explore potential acquisitions to bolster its technology and market presence, although no significant acquisitions were reported during the fiscal year.

Operationally, the company has seen fluctuations in customer engagement, with service revenue primarily tied to exploration and production activities in the oil and gas sector. The average U.S. land-based rig count decreased by 6% in 2025, impacting demand for product sales. However, international markets showed resilience, with a 20% increase in rig counts in 2024, although this was followed by a 7% decline in 2025. Core Laboratories remains committed to leveraging its proprietary technologies and expanding its service offerings to meet evolving client needs, particularly in carbon capture and sequestration projects.

Looking ahead, Core Laboratories anticipates continued volatility in commodity prices due to geopolitical tensions and OPEC+ production adjustments. The company expects that while short-cycle projects may be sensitive to price fluctuations, larger international projects will remain stable. Core Laboratories is focused on maintaining operational efficiency and adapting to market conditions, with an emphasis on capital management and return on investment for its clients. The outlook remains cautious, with ongoing monitoring of geopolitical developments and their potential impact on the oil and gas industry.